A Randomized Trial of Plasmapheresis and Subsequent Pulse Cyclophosphamide in Severe Lupus: Design of the Lpsg Trial (Q67774884)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: design of the LPSG trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

A Randomized Trial of Plasmapheresis and Subsequent Pulse Cyclophosphamide in Severe Lupus: Design of the Lpsg Trial (English)

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

15 November 2022

main subject

biomedical engineering

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

15 November 2022

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

15 November 2022

author name string

H. H. Euler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748532

15 November 2022

J. O. Schroeder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748532

15 November 2022

R. A. Zeuner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748532

15 November 2022

E. Teske

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748532

15 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1748532

15 November 2022

publication date

1 October 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

http://journals.sagepub.com/doi/pdf/10.1177/039139889101401007

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

International Journal of Artificial Organs

15 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

639-646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

15 November 2022

3

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis

15 November 2022

5

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease

15 November 2022

6

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

NIH conference. Lupus nephritis

15 November 2022

7

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

15 November 2022

9

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus

15 November 2022

10

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Plasmapheresis in the management of acute systemic lupus erythematosus?

15 November 2022

11

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

La Semaine des hopitaux de Paris

15 November 2022

12

62

453

Gayraud M.

1986

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Reversal of Impaired Splenic Function in Patients with Nephritis or Vasculitis (or Both) by Plasma Exchange

15 November 2022

15

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

The nonspecific clearance function of the reticuloendothelial system in patients with immune complex mediated diseases before and after therapeutic plasmapheresis

15 November 2022

16

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion

15 November 2022

17

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

The Quarterly Journal of Medicine

15 November 2022

19

48

555

Jones J.V.

1979

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Plasmapheresis in systemic lupus erythematosus: a cautionary note

15 November 2022

21

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Randomised trial of plasma exchange in mild systemic lupus erythematosus

15 November 2022

23

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus

15 November 2022

26

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA.

15 November 2022

28

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus

15 November 2022

29

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris

15 November 2022

30

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Plasmapheresis and pulse cyclophosphamide in systemic lupus erythematosus

15 November 2022

32

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Measurement of systemic lupus erythematosus activity in clinical research

15 November 2022

34

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

15 November 2022

35

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

Predictive value of clinical, laboratory, pathologic, and treatment variables in steroid/lmmunosuppressive resistant lupus nephritis

15 November 2022

36

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

15 November 2022

37

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

The 1982 revised criteria for the classification of systemic lupus erythematosus

15 November 2022

38

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

The Journal of Rheumatology

15 November 2022

42

11

783

Urowitz M.B.

1984

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

The Quarterly Journal of Medicine

15 November 2022

43

202

125

Morrow W.J.W.

1982

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

The Quarterly Journal of Medicine

15 November 2022

44

258

927

Symmons D.P.M.

1988

1 reference

https://api.crossref.org/works/10.1177/039139889101401007

15 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1748532%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference